These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1279828)

  • 21. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents].
    Frank R; Raguin D; Tonet J; Fontaine G
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():21-5. PubMed ID: 1726995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The efficacy of complex therapy of ventricular arrhythmias with emoxipin and preductal in combination with antiarrhythmic agents].
    Kotliarov AA; Mosina LM; Kairakina TN; Chibisov SM; Kulikov SI
    Klin Med (Mosk); 2007; 85(12):22-6. PubMed ID: 18318161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative clinical study of the effectiveness of the new anti-arrhythmia agents, trimecaine and pyrromecaine].
    Pavlova TS; Riabokon' OS; Ivanova LA; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):67-72. PubMed ID: 6196040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication?
    Kim C; Yokozuka M; Sato C; Nakanishi K; Kitamura A; Sakamoto A
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):564-7. PubMed ID: 17875037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
    Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
    J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Idiopathic ventricular extrasystole : right ventricular parasystole not protected from the sinus rhythm?].
    Leclercq JF; Rosengarten MD; Attuel P; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1249-61. PubMed ID: 6172085
    [No Abstract]   [Full Text] [Related]  

  • 30. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
    Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS; Kane-Gill SL; Rudis MI; Seybert AL; Oyen LJ; Ou NN; Stauss JL; Kirisci L; Idrees U; Henderson SO
    Crit Care Med; 2006 Jun; 34(6):1617-23. PubMed ID: 16614583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differential therapy of ventricular arrhythmias].
    Haberl R
    Z Arztl Fortbild (Jena); 1993; 87(5 Suppl 3):1-3. PubMed ID: 8212745
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experiences with a new anti-arrhythmia agent propafenon].
    Seipel L; Fischer G; Wiebringhaus E
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1229-31. PubMed ID: 70898
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical significance of electrophysiologic drug testing in the longterm therapy of class I, III and IV antiarrhythmic drugs for recurrent ventricular tachyarrhythmia].
    Kasanuki H; Ohnishi S; Amamiya K; Umemura J; Shoda M; Hosoda S
    Jpn Circ J; 1992; 56 Suppl 5():1458-61. PubMed ID: 1291742
    [No Abstract]   [Full Text] [Related]  

  • 37. [The pharmacokinetics and pharmacodynamics of the new Soviet anti-arrhythmia preparation allapinin].
    Abdalla A; Rulin VA; Mazur NA; Chikovani SI
    Farmakol Toksikol; 1988; 51(5):47-9. PubMed ID: 2463182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia].
    Mestre JL; Moro C; Madrid AH; Novo L; Marín-Huerta E
    Rev Esp Cardiol; 1994 Jul; 47(7):461-7. PubMed ID: 8090973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential indications for anti-arrhythmia therapy].
    Manz M; Wagner WL; Lüderitz B
    Internist (Berl); 1987 Mar; 28(3):182-9. PubMed ID: 2438248
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.